- Supported exchanges /
- SHE /
- 300039.SHE
Shanghai Kaibao Pharmaceutical (300039 SHE) stock market data APIs
Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern Chinese medicines primarily in China. Its primary products include Tanreqing injection for the treatment of pneumonia, acute and chronic bronchitis, and upper respiratory tract infection; Tanreqing capsules that clears heat and detoxifies and removes phlegm; tiopronin for injection, which improves liver function of various acute and chronic hepatitis; Tiopronin enteric-coated tablets for adjuvant treatment of chronic hepatitis; and Xiongdan dropping pills that clears heat, calms liver, and improves eyesight. The company was founded in 2000 and is based in Shanghai, China.
Shanghai Kaibao Pharmaceutical Financial Data Overview
| 6.4 | |
| 6.69 | |
| - | |
| 6.72 | |
| 6.38 | |
| 4.9-7.7429 | |
| 7 019 M | |
| 20.3333 | |
| 1 046 M | |
| 1 561 M | |
| 0.0716 | |
| 0.0149 | |
| 0.23 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Shanghai Kaibao Pharmaceutical Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 561 M
- EBITDA 362 M
- Earnings Per Share 0.33
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Shanghai Kaibao Pharmaceutical Earnings via APIs
- Latest Release 2024-10-25
- EPS/Forecast NaN
Get Shanghai Kaibao Pharmaceutical End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
